By Kamal Choudhury and Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
The drug is approved for acute myeloid leukemia patients with an NPM1 mutation, a genetic change found in about 30% of cases.
Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow.
Kura said the drug will be available within the next few business days at a price of $48,500 for a one-month supply.
With the approval, Kura's drug now competes with Syndax Pharmaceuticals' Revuforj, which was approved for the same indication by the FDA last month.
Komzifti’s approval comes with a boxed warning for differentiation syndrome and an additional warning for QTc interval prolongation, a delay in the heart’s electrical recovery after a beat, and potential harm to unborn babies.
A boxed warning is the U.S. Food and Drug Administration’s strongest alert for serious or life-threatening risks and appears prominently on a drug’s label to warn doctors and patients.
Revuforj carries a boxed warning for QTc interval prolongation, giving Kura “a significant competitive advantage,” according to Wedbush analysts.
Kura's Chief Medical Officer Mollie Leoni said the risk of QTc prolongation with Komzifti is low, adding it is “extraordinarily unlikely” to lead to a boxed warning.
The company said it is in dialogue with the FDA about potential steps post-approval that could help refine the labeling.
Under the terms of its collaboration with Kyowa, Kura is responsible for manufacturing Komzifti and will lead commercialization in the United States, while Kyowa handles commercial strategy and development outside the U.S.
Analysts, on average, expect Komzifti to have annual sales of $1.32 billion by 2031, according to LSEG data.
(Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid)
latest_posts
- 1
Brazil's ex-president Bolsonaro operated on for hernia - 223 Most Amusing Messages At any point Sent Among Youngsters and Their Folks
- 3Google's proposed data center in orbit will face issues with space debris in an already crowded orbit
- 4Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
- 54 Home Rec center Hardware Decisions for Little Spaces
- Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
- Display of Netanyahu's severed head 'incites public to murder PM', Likud says in official complaint
- Astronauts' brains change shape and position after time in space, study finds
- The Beginning Of The End For Fossil Fuels Can Start In Colombia
- Coalition led by Iraqi PM al-Sudani wins parliamentary elections
- Thousands of ultra-orthodox protest in Jerusalem against conscription
- Astrophotographer captures rare footage of the Hubble Telescope crossing the sun (video)
- Cathay Pacific raises fuel surcharge on all flights by 34%
- Iranian naval commander Alireza Tangsiri killed in attack, says Israel
